CN Patent

CN114040762A — 使用葡糖神经酰胺合酶(gcs)的抑制剂治疗纤毛疾病

Assigned to Genzyme Corp · Expires 2022-02-11 · 4y expired

What this patent protects

本公开文本涉及一种治疗受试者中的纤毛疾病的方法，所述方法包括向所述受试者施用有效量的奎宁环化合物。还公开了一种用于所述方法中的包含奎宁环化合物的药物组合物。

USPTO Abstract

本公开文本涉及一种治疗受试者中的纤毛疾病的方法，所述方法包括向所述受试者施用有效量的奎宁环化合物。还公开了一种用于所述方法中的包含奎宁环化合物的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN114040762A
Jurisdiction
CN
Classification
—
Expires
2022-02-11
Drug substance claim
No
Drug product claim
No
Assignee
Genzyme Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.